ZIMMER BIOMET HOLDINGS, INC. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $2.01 billion for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-08-06
- ZIMMER BIOMET HOLDINGS, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $2.01B, a 2.98% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $2.02B, a 2.29% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $2.07B, a 3.04% increase year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $1.82B, a 0.80% decline year-over-year.
- ZIMMER BIOMET HOLDINGS, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $7.82B, a 1.82% increase from fiscal 2016.
- ZIMMER BIOMET HOLDINGS, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $7.68B, a 28.11% increase from fiscal 2015.
- ZIMMER BIOMET HOLDINGS, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $6.00B, a 28.34% increase from fiscal 2014.
- ZIMMER BIOMET HOLDINGS, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $4.67B, a 1.08% increase from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|---|
| 2018-06-30 | $2.01B 10-Q · filed 2018-08-06 | $4.03B 10-Q · filed 2018-08-06 | $6.10B derived: sum of 3 quarters · filed 2018-08-06 | $7.92B derived: sum of 4 quarters · filed 2018-08-06 | ||
| 2018-03-31 | $2.02B 10-Q · filed 2018-05-08 | $4.09B derived: sum of 2 quarters · filed 2018-05-08 | $5.91B derived: sum of 3 quarters · filed 2018-05-08 | $7.86B derived: sum of 4 quarters · filed 2018-08-06 | ||
| 2017-12-31 | $2.07B 10-K · filed 2018-02-27 | $3.89B derived: sum of 2 quarters · filed 2018-02-27 | $5.84B derived: sum of 3 quarters · filed 2018-08-06 | $7.82B 10-K · filed 2018-02-27 | ||
| 2017-09-30 | $1.82B 10-K · filed 2018-02-27 | $3.77B derived: sum of 2 quarters · filed 2018-08-06 | $5.75B 10-Q · filed 2017-11-06 | $7.75B derived: sum of 4 quarters · filed 2018-08-06 | ||
| 2017-06-30 | $1.95B 10-Q · filed 2018-08-06 | $1.95B 10-Q · filed 2017-08-08 | $3.92B 10-Q · filed 2018-08-06 | $3.93B 10-Q · filed 2017-08-08 | $5.93B derived: sum of 3 quarters · filed 2018-08-06 | $7.77B derived: sum of 4 quarters · filed 2018-08-06 |
| 2017-03-31 | $1.97B 10-Q · filed 2018-05-08 | $1.98B 10-Q · filed 2017-05-09 | $3.99B derived: sum of 2 quarters · filed 2018-05-08 | $5.82B derived: sum of 3 quarters · filed 2018-05-08 | $7.75B derived: sum of 4 quarters · filed 2018-05-08 | |
| 2016-12-31 | $2.01B 10-K · filed 2018-02-27 | $3.85B derived: sum of 2 quarters · filed 2018-02-27 | $5.78B derived: sum of 3 quarters · filed 2018-02-27 | $7.68B 10-K · filed 2018-02-27 | ||
| 2016-09-30 | $1.83B 10-K · filed 2018-02-27 | $3.77B derived: sum of 2 quarters · filed 2018-02-27 | $5.67B 10-Q · filed 2017-11-06 | $7.60B derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-06-30 | $1.93B 10-K · filed 2018-02-27 | $3.84B 10-Q · filed 2017-08-08 | $5.77B derived: sum of 3 quarters · filed 2018-02-27 | $7.53B derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-03-31 | $1.90B 10-K · filed 2018-02-27 | $3.84B derived: sum of 2 quarters · filed 2018-02-27 | $5.60B derived: sum of 3 quarters · filed 2018-02-27 | $6.77B derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $1.93B 10-K · filed 2017-03-01 | $3.70B derived: sum of 2 quarters · filed 2017-03-01 | $4.86B derived: sum of 3 quarters · filed 2017-03-01 | $6.00B 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $1.76B 10-K · filed 2017-03-01 | $2.93B derived: sum of 2 quarters · filed 2017-03-01 | $4.06B 10-Q · filed 2016-11-08 | $5.29B derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-06-30 | $1.17B 10-K · filed 2017-03-01 | $2.30B 10-Q · filed 2016-08-08 | $3.52B derived: sum of 3 quarters · filed 2017-03-01 | $4.63B derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-03-31 | $1.13B 10-K · filed 2017-03-01 | $2.36B derived: sum of 2 quarters · filed 2017-03-01 | $3.46B derived: sum of 3 quarters · filed 2017-03-01 | $4.65B derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2014-12-31 | $1.22B 10-K · filed 2016-02-29 | $2.33B derived: sum of 2 quarters · filed 2016-02-29 | $3.51B derived: sum of 3 quarters · filed 2016-02-29 | $4.67B 10-K · filed 2017-03-01 | ||
| 2014-09-30 | $1.11B 10-K · filed 2016-02-29 | $2.29B derived: sum of 2 quarters · filed 2016-02-29 | $3.45B 10-Q · filed 2015-11-09 | $4.69B derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-30 | $1.18B 10-K · filed 2016-02-29 | $2.34B 10-Q · filed 2015-08-10 | $3.59B derived: sum of 3 quarters · filed 2016-02-29 | $4.66B derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-03-31 | $1.16B 10-K · filed 2016-02-29 | $2.40B derived: sum of 2 quarters · filed 2016-02-29 | $3.48B derived: sum of 3 quarters · filed 2016-02-29 | $4.65B derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $1.24B 10-K · filed 2015-02-23 | $2.31B derived: sum of 2 quarters · filed 2015-02-23 | $3.48B derived: sum of 3 quarters · filed 2015-02-23 | $4.62B 10-K · filed 2016-02-29 | ||
| 2013-09-30 | $1.07B 10-K · filed 2015-02-23 | $2.24B derived: sum of 2 quarters · filed 2015-02-23 | $3.38B 10-Q · filed 2014-11-05 | $4.56B derived: sum of 4 quarters · filed 2015-02-23 | ||
| 2013-06-30 | $1.17B 10-K · filed 2015-02-23 | $2.31B 10-Q · filed 2014-08-07 | $3.49B derived: sum of 3 quarters · filed 2015-02-23 | $4.51B derived: sum of 4 quarters · filed 2015-02-23 | ||
| 2013-03-31 | $1.14B 10-K · filed 2015-02-23 | $2.32B derived: sum of 2 quarters · filed 2015-02-23 | $3.34B derived: sum of 3 quarters · filed 2015-02-23 | $4.47B derived: sum of 4 quarters · filed 2015-02-23 | ||
| 2012-12-31 | $1.18B 10-K · filed 2014-02-28 | $2.21B derived: sum of 2 quarters · filed 2014-02-28 | $3.33B derived: sum of 3 quarters · filed 2014-02-28 | $4.47B 10-K · filed 2015-02-23 | ||
| 2012-09-30 | $1.03B 10-K · filed 2014-02-28 | $2.15B derived: sum of 2 quarters · filed 2014-02-28 | $3.29B 10-Q · filed 2013-11-12 | $4.46B derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-06-30 | $1.13B 10-K · filed 2014-02-28 | $2.27B 10-Q · filed 2013-08-07 | $3.43B derived: sum of 3 quarters · filed 2014-02-28 | $4.46B derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-03-31 | $1.14B 10-K · filed 2014-02-28 | $2.31B derived: sum of 2 quarters · filed 2014-02-28 | $3.34B derived: sum of 3 quarters · filed 2014-02-28 | $4.48B derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2011-12-31 | $1.17B 10-K · filed 2013-02-27 | $2.20B derived: sum of 2 quarters · filed 2013-02-27 | $3.34B derived: sum of 3 quarters · filed 2013-02-27 | $4.45B 10-K · filed 2014-02-28 | ||
| 2011-09-30 | $1.03B 10-K · filed 2013-02-27 | $2.17B derived: sum of 2 quarters · filed 2013-02-27 | $3.28B 10-Q · filed 2012-11-06 | $4.42B derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2011-06-30 | $1.14B 10-K · filed 2013-02-27 | $2.25B 10-Q · filed 2012-08-07 | $3.39B derived: sum of 3 quarters · filed 2013-02-27 | $4.35B derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2011-03-31 | $1.12B 10-K · filed 2013-02-27 | $2.25B derived: sum of 2 quarters · filed 2013-02-27 | $3.22B derived: sum of 3 quarters · filed 2013-02-27 | $4.27B derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2010-12-31 | $1.13B 10-K · filed 2012-02-27 | $2.10B derived: sum of 2 quarters · filed 2012-02-27 | $3.16B derived: sum of 3 quarters · filed 2012-02-27 | $4.22B 10-K · filed 2013-02-27 | ||
| 2010-09-30 | $965.00M 10-K · filed 2012-02-27 | $2.02B derived: sum of 2 quarters · filed 2012-02-27 | $3.09B 10-Q · filed 2011-11-02 | |||
| 2010-06-30 | $1.06B 10-K · filed 2012-02-27 | $2.12B 10-Q · filed 2011-08-08 | ||||
| 2010-03-31 | $1.06B 10-K · filed 2012-02-27 | |||||
| 2009-12-31 | $4.10B 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |